These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14583584)

  • 1. Low dose methotrexate osteopathy in a patient with polyarticular juvenile idiopathic arthritis.
    Quinn MA; Green MJ; Gough AK
    Ann Rheum Dis; 2003 Nov; 62(11):1123-4; author reply 1124. PubMed ID: 14583584
    [No Abstract]   [Full Text] [Related]  

  • 2. Is methotrexate osteopathy a form of bone idiosyncrasy?
    Rozin AP
    Ann Rheum Dis; 2003 Nov; 62(11):1123; author reply 1124. PubMed ID: 14583585
    [No Abstract]   [Full Text] [Related]  

  • 3. Low dose methotrexate osteopathy in a patient with polyarticular juvenile idiopathic arthritis.
    Rudler M; Pouchot J; Paycha F; Gentelle S; Grasland A; Vinceneux P
    Ann Rheum Dis; 2003 Jun; 62(6):588-9. PubMed ID: 12759303
    [No Abstract]   [Full Text] [Related]  

  • 4. Polyarticular juvenile idiopathic arthritis treated with methotrexate complicated by the development of non-Hodgkin's lymphoma.
    Cleary AG; McDowell H; Sills JA
    Arch Dis Child; 2002 Jan; 86(1):47-9. PubMed ID: 11806884
    [No Abstract]   [Full Text] [Related]  

  • 5. Methotrexate-induced hypersensitivity pneumonitis in a child with juvenile rheumatoid arthritis.
    Cron RQ; Sherry DD; Wallace CA
    J Pediatr; 1998 May; 132(5):901-2. PubMed ID: 9602213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophilia as a side-effect of methotrexate in patients with chronic arthritis.
    Savolainen HA; Leirisalo-Repo M
    Clin Rheumatol; 2001; 20(6):432-4. PubMed ID: 11771529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor inhibitors and cancer in juvenile idiopathic arthritis: disentangling the web.
    Onel KB; Onel K
    Arthritis Rheum; 2012 Apr; 64(4):966-9. PubMed ID: 22327954
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the benefits of sequential addition of leflunomide in patients with polyarticular course juvenile idiopathic arthritis failing standard dose methotrexate.
    Chickermane PR; Khubchandani RP
    Clin Exp Rheumatol; 2015; 33(2):287-92. PubMed ID: 25738527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of methotrexate response in Turkish children with oligoarticular and polyarticular juvenile idiopathic arthritis.
    Batu ED; Sönmez HE; Gülhan B; Arıcı ZS; Topaloğlu R; Bilginer Y
    Turk J Pediatr; 2017; 59(1):6-12. PubMed ID: 29168357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of methotrexate in children with rheumatic diseases.
    Gutiérrez-Suárez R; Burgos-Vargas R
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S122-7. PubMed ID: 21044445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contradictory and weak evidence on the effectiveness of anti-emetics for MTX-intolerance in JIA-patients.
    Schoemaker CG; van Dijkhuizen EHP; Vastert SJ
    Pediatr Rheumatol Online J; 2018 Feb; 16(1):13. PubMed ID: 29448947
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA).
    Klotsche J; Niewerth M; Haas JP; Huppertz HI; Zink A; Horneff G; Minden K
    Ann Rheum Dis; 2016 May; 75(5):855-61. PubMed ID: 25926155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study.
    van Dijkhuizen EH; Bulatović Ćalasan M; Pluijm SM; de Rotte MC; Vastert SJ; Kamphuis S; de Jonge R; Wulffraat NM
    Pediatr Rheumatol Online J; 2015; 13():5. PubMed ID: 25745368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate-Induced Vasculitis in a Child with Systemic Onset Juvenile Idiopathic Arthritis.
    Markham R; Whittam LR; Armstrong J; Wilkinson N; Williamson L
    J Clin Rheumatol; 2021 Sep; 27(6):e206-e208. PubMed ID: 30431484
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of methotrexate in juvenile idiopathic arthritis.
    Ramanan AV; Whitworth P; Baildam EM
    Arch Dis Child; 2003 Mar; 88(3):197-200. PubMed ID: 12598376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids in juvenile idiopathic arthritis.
    Malattia C; Martini A
    Ann N Y Acad Sci; 2014 May; 1318():65-70. PubMed ID: 24738483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of methotrexate on the temporomandibular joint and facial morphology in juvenile rheumatoid arthritis patients.
    Ince DO; Ince A; Moore TL
    Am J Orthod Dentofacial Orthop; 2000 Jul; 118(1):75-83. PubMed ID: 10893476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for the prevention and management of methotrexate-related nausea and vomiting in juvenile idiopathic arthritis: results of a UK Paediatric Rheumatology prescriber survey.
    Amin TS; Shenton S; Mulligan K; Wedderburn LR; Wood M; VanRooyen V; Leone V
    Rheumatology (Oxford); 2015 Nov; 54(11):2108-9. PubMed ID: 26209331
    [No Abstract]   [Full Text] [Related]  

  • 19. Associations between gene polymorphisms and treatment outcomes of methotrexate in patients with juvenile idiopathic arthritis.
    Chen Y; Zou K; Sun J; Yang Y; Liu G
    Pharmacogenomics; 2018 Apr; 19(6):529-538. PubMed ID: 29589488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In the Pursuit of Methotrexate Treatment Response Biomarker in Juvenile Idiopathic Arthritis-Are We Getting Closer to Personalised Medicine?
    Roszkiewicz J; Smolewska E
    Curr Rheumatol Rep; 2017 Apr; 19(4):19. PubMed ID: 28361333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.